{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:36:27Z","timestamp":1760204187168},"reference-count":16,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"4605","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1983,7]]},"abstract":"<jats:p>Dopamine was transformed into a redox chemical system for delivery to the brain. The lipoidal form allowed penetration of the blood-brain barrier. Oxidative and hydrolytic processes then transformed the delivery form into a quaternary ammonium precursor of dopamine. The quaternary ammonium precursor was rapidly eliminated from the general circulation, whereas that formed in the brain was locked in, thereby providing a significant and sustained brain-specific dopaminergic activity.<\/jats:p>","DOI":"10.1126\/science.6857264","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T18:37:18Z","timestamp":1160073438000},"page":"65-67","source":"Crossref","is-referenced-by-count":66,"title":["Redox Delivery System for Brain-Specific, Sustained Release of Dopamine"],"prefix":"10.1126","volume":"221","author":[{"given":"Nicholas","family":"Bodor","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville 32610"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Simpkins","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville 32610"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-6147(81)90346-1","volume":"2","year":"1981","unstructured":"BARBEAU, A, THE USE OF L-DOPA IN PARKINSONS-DISEASE - A 20 YEAR FOLLOW-UP, TRENDS IN PHARMACOLOGICAL SCIENCES 2: 297 (1981).","journal-title":"TRENDS IN PHARMACOLOGICAL SCIENCES"},{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/jm00357a002","volume":"26","year":"1983","unstructured":"BODOR, N, IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .11. A REDOX CHEMICAL DRUG-DELIVERY SYSTEM AND ITS USE FOR BRAIN-SPECIFIC DELIVERY OF PHENYLETHYLAMINE, JOURNAL OF MEDICINAL CHEMISTRY 26: 313 (1983).","journal-title":"JOURNAL OF MEDICINAL CHEMISTRY"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1126\/science.7313698","volume":"214","year":"1981","unstructured":"BODOR, N, SITE-SPECIFIC, SUSTAINED-RELEASE OF DRUGS TO THE BRAIN, SCIENCE 214: 1370 (1981).","journal-title":"SCIENCE"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/endo-99-3-914","volume":"99","year":"1976","unstructured":"CHEUNG, C.Y., SUPERSENSITIVITY OF ANTERIOR-PITUITARY DOPAMINE RECEPTORS INVOLVED IN INHIBITION OF PROLACTIN SECRETION FOLLOWING DESTRUCTION OF MEDIAL BASAL HYPOTHALAMUS, ENDOCRINOLOGY 99: 914 (1976).","journal-title":"ENDOCRINOLOGY"},{"key":"e_1_2_1_5_1","first-page":"230","volume":"79","year":"1975","unstructured":"CLEMENS, J.A., INHIBITION OF PROLACTIN SECRETION BY LERGOTRILE MESYLATE - MECHANISM OF ACTION, ACTA ENDOCRINOLOGICA 79: 230 (1975).","journal-title":"ACTA ENDOCRINOLOGICA"},{"key":"e_1_2_1_6_1","first-page":"130","volume":"41","year":"1964","unstructured":"DOBBINS, J, PHYSL REV 41: 130 (1964).","journal-title":"PHYSL REV"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/endo-100-3-722","volume":"100","year":"1977","unstructured":"DURAND, D, EVIDENCE FOR A ROLE OF ALPHA-ADRENERGIC MECHANISMS IN REGULATION OF EPISODIC GROWTH-HORMONE SECRETION IN RAT, ENDOCRINOLOGY 100: 722 (1977).","journal-title":"ENDOCRINOLOGY"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","year":"1960","unstructured":"EHRINGER, H, VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS, KLINISCHE WOCHENSCHRIFT 38: 1236 (1960).","journal-title":"KLINISCHE WOCHENSCHRIFT"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/endo-96-2-313","volume":"96","year":"1975","unstructured":"LAWSON, D.M., INFLUENCE OF ADRENERGIC, DOPAMINERGIC, CHOLINERGIC AND SEROTONINERGIC DRUGS ON PLASMA PROLACTIN LEVELS IN OVARIECTOMIZED, ESTROGEN-TREATED RATS, ENDOCRINOLOGY 96: 313 (1975).","journal-title":"ENDOCRINOLOGY"},{"key":"e_1_2_1_10_1","first-page":"169","volume":"4","year":"1976","unstructured":"MacLeod, R. M., Frontiers in Neuroendocrinoioy 4: 169 (1976).","journal-title":"Frontiers in Neuroendocrinoioy"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/ja00383a048","volume":"104","year":"1982","unstructured":"Miller, L. L., Journal of the American Chemical Society 104: 5242 (1982).","journal-title":"Journal of the American Chemical Society"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000122476","volume":"20","year":"1976","unstructured":"MUELLER, G.P., DIFFERENTIAL EFFECTS OF DOPAMINE AGONISTS AND HALOPERIDOL ON RELEASE OF PROLACTIN, THYROID STIMULATING HORMONE, GROWTH-HORMONE AND LUTEINIZING-HORMONE IN RATS, NEUROENDOCRINOLOGY 20: 121 (1976).","journal-title":"NEUROENDOCRINOLOGY"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0024-3205(64)90007-4","volume":"3","year":"1964","unstructured":"ROOS, B.E., THE EFFECT OF L-3,4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE, LIFE SCIENCES 3: 351 (1964).","journal-title":"LIFE SCIENCES"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.7326\/0003-4819-90-6-949","volume":"90","year":"1979","unstructured":"SPARK, R.F., BROMOCRIPTINE AND ENDOCRINE DISORDERS, ANNALS OF INTERNAL MEDICINE 90: 949 (1979).","journal-title":"ANNALS OF INTERNAL MEDICINE"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/endo-88-3-737","volume":"88","year":"1971","unstructured":"WUTTKE, W, EFFECTS OF ERGOCORNINE ON SERUM PROLACTIN AND LH, AND ON HYPOTHALAMIC CONTENT OF PIF AND LRF, ENDOCRINOLOGY 88: 737 (1971).","journal-title":"ENDOCRINOLOGY"},{"key":"e_1_2_1_16_1","first-page":"321","volume":"41","year":"1962","unstructured":"ZEILMAKER, G.H., EXPERIMENTAL STUDIES ON EFFECT OF ERGOCORNINE METHANESULPHONATE ON LUTEOTROPHIC FUNCTION OF RAT PITUITARY GLAND, ACTA ENDOCRINOLOGICA 41: 321 (1962).","journal-title":"ACTA ENDOCRINOLOGICA"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.6857264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T22:34:55Z","timestamp":1705271695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.6857264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,7]]},"references-count":16,"journal-issue":{"issue":"4605","published-print":{"date-parts":[[1983,7]]}},"alternative-id":["10.1126\/science.6857264"],"URL":"https:\/\/doi.org\/10.1126\/science.6857264","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,7]]}}}